Your doctor mentioned switching from Lantus to Toujeo, or maybe you’re starting long-acting insulin for the first time and trying to understand which option makes more sense.
The answer depends on your specific situation. Both insulins work well for managing diabetes. Toujeo lasts slightly longer and has a flatter profile, making it better for people who experience end-of-dose blood sugar rises or frequent nighttime lows. Lantus works for most people and is often more affordable because biosimilar versions exist.
Both insulins contain the same active ingredient, insulin glargine, and provide steady background insulin coverage for 24 hours. Understanding the differences helps you make an informed decision with your doctor.
The Key Difference: Concentration
The main distinction between these insulins is concentration. Lantus contains 100 units of insulin per milliliter, written as U-100. This is the standard concentration used by most insulins.
Toujeo contains 300 units per milliliter, or U-300.
This makes Toujeo three times more concentrated than Lantus.
Higher concentration changes how the insulin behaves after injection. When you inject a more concentrated solution, it forms a smaller depot under your skin. This smaller depot releases insulin more slowly and steadily over a longer period.
Clinical studies suggest Toujeo lasts 24 to 36 hours while Lantus lasts closer to 24 hours. This extended duration can matter depending on your individual insulin needs and blood sugar patterns.
How This Affects Your Blood Sugar
According to the Centers for Disease Control and Prevention, over 38 million Americans have diabetes. For people using insulin, consistency in blood sugar control makes a significant difference in both daily quality of life and long-term health outcomes.
Some people find that Lantus starts wearing off after 20 to 22 hours.
For example, if you inject at 8 PM, your blood sugar might start rising by 6 PM the next day, a few hours before your next dose. This shows up as higher blood sugar in the late afternoon or early evening.
Toujeo’s extended duration means it’s more likely to provide coverage for a full 24 hours without that end-of-dose rise. For people who experience this issue with Lantus, switching to Toujeo often results in more consistent blood sugar throughout the entire day.
The flatter profile of Toujeo also means less peak insulin activity. Lantus has a slightly higher peak a few hours after injection, which can increase the risk of low blood sugar during that time, particularly overnight. Toujeo’s steadier action reduces this risk somewhat.
Dosing Differences
Because Toujeo is more concentrated, switching from Lantus to Toujeo isn’t a simple unit-for-unit conversion. Most people need the same number of units or slightly more when switching.
Your doctor will determine your starting dose based on your current insulin regimen and blood sugar patterns.
You’ll likely monitor your blood sugar more frequently when switching to make sure the dose is right.
The higher concentration of Toujeo means you inject a smaller volume to get the same number of units. If your Lantus dose is 30 units, you inject 0.3 milliliters. With Toujeo, that same 30 units takes up only 0.1 milliliters. The smaller injection volume can be more comfortable, particularly for people taking higher doses.
Both insulins require dose adjustments over time as your needs change based on factors like weight, activity level, other medications, stress, and illness.
Hypoglycemia Risk
Low blood sugar is a concern with any insulin. Both Toujeo and Lantus can cause hypoglycemia if the dose is too high relative to your food intake and activity level.
Clinical studies have found slightly lower rates of nighttime hypoglycemia with Toujeo compared to Lantus. The flatter profile means less peak insulin activity overnight, which reduces the chance of blood sugar dropping too low while you sleep.
This difference is modest rather than dramatic.
Both insulins are relatively safe in terms of hypoglycemia risk. For someone who experiences frequent nighttime lows, though, the slightly lower risk with Toujeo might be reason enough to prefer it.
Preventing hypoglycemia involves more than just insulin choice. Eating consistent amounts of carbohydrates, timing meals appropriately, adjusting insulin doses based on activity, and monitoring blood sugar regularly all play important roles.
Weight Considerations
Insulin therapy can cause weight gain. When blood sugar is high, you lose calories in your urine as glucose. Once insulin brings blood sugar under control, those calories stay in your body.
Toujeo and Lantus show similar weight effects for both insulins. Neither has a clear advantage in terms of avoiding weight gain. The amount varies considerably between individuals and depends more on diet, physical activity, and other medications than on which specific insulin you use.
Injection Experience and Storage
Both insulins come in prefilled pens designed for easy use. The needles and injection technique are the same. You inject into fatty areas like your abdomen, thighs, or upper arms, rotating injection sites to prevent tissue buildup that can affect insulin absorption.
The main difference is injection volume.
With Lantus, you inject whatever volume corresponds to your dose at standard concentration. With Toujeo, you inject a smaller volume for the same number of units because of the higher concentration.
Both insulins require similar storage. Unopened pens should be refrigerated. Once you start using a pen, you can keep it at room temperature for up to 28 days. Never freeze insulin, as freezing destroys its effectiveness. Protect insulin from extreme heat and direct sunlight.
Check your insulin before each injection. It should be clear and colorless. If it looks cloudy, discolored, or contains particles, don’t use it.
Cost and Insurance Coverage
Cost can be a major factor in insulin choice. Both Toujeo and Lantus are expensive without insurance coverage.
Insurance plans vary in which insulin they prefer.
Some plans place Lantus on a more favorable tier with lower copays because biosimilar versions exist. Others cover both insulins similarly.
Lantus now has biosimilar versions available, including Basaglar and Semglee, which are often less expensive than brand-name Lantus. Toujeo doesn’t have biosimilar equivalents yet, which can make it more expensive depending on your insurance coverage.
Your insurance formulary determines your out-of-pocket cost, which can differ significantly between these insulins. Checking with your insurance plan about coverage and copays for each option should be part of your decision-making process.
Which Insulin Makes Sense for You?
Several factors should guide your choice:
- If your blood sugar rises in the hours before your next insulin dose, Toujeo’s longer duration might help. This shows up as consistent late afternoon or early evening highs.
- If you experience nighttime low blood sugar frequently, Toujeo’s slightly lower hypoglycemia risk might be beneficial.
- If you’re taking high doses of insulin, Toujeo’s more concentrated formulation means smaller injection volumes.
- If cost is your primary concern, Lantus or its biosimilar versions might be more affordable.
The clinical differences between these insulins are modest enough that cost can reasonably drive the decision if one is significantly more affordable.
If you’re currently stable on Lantus with good blood sugar control and no problems with nighttime lows or end-of-dose rises, there may be no compelling reason to switch. Stability in diabetes management has real value.
Talking With Your Doctor
If you’re considering switching between these insulins or choosing one for the first time, bring specific information to your appointment.
Share your blood sugar patterns, particularly your fasting blood sugar when you wake up and your blood sugar right before your next insulin dose. These patterns help your doctor see whether insulin duration is an issue.
Mention any episodes of low blood sugar, especially if they happen at night or in the early morning hours.
The timing and frequency of lows influences which insulin might work better.
Be honest about cost concerns. Your doctor can work with you to find the most affordable option, whether that means choosing a specific insulin, accessing patient assistance programs, or adjusting your overall treatment plan.
Ask about what to expect when switching. Will your dose stay the same? How often should you check your blood sugar during the transition?
Making the Decision
Toujeo and Lantus are more similar than different. Both are effective long-acting insulin glargine products that help control fasting blood sugar. The concentration difference leads to modest differences in duration of action and hypoglycemia risk.
The choice often comes down to individual patterns, preferences, and practical factors like cost.
Working closely with your doctor and monitoring your blood sugar carefully helps you find the right fit.
Diabetes management requires ongoing adjustment. What works well for you now might need to change as your situation changes. Staying flexible and communicating openly with your healthcare team gives you the best chance of maintaining good blood sugar control.
Managing diabetes is challenging enough without worrying about affording your insulin. The Rx Advocates specializes in helping people access Toujeo, Lantus, and biosimilar alternatives through manufacturer patient assistance programs. These programs can provide your insulin at little to no cost if you meet eligibility requirements.
Contact us online or call us at (844) 559-8331 today to see if you qualify and let us handle the paperwork while you focus on your health.